PT  - JOURNAL ARTICLE
AU  - Tavankit Singh
AU  - Daniela S. Allende
AU  - Arthur J. McCullough
TI  - Assessing liver fibrosis without biopsy in patients with HCV or NAFLD
AID  - 10.3949/ccjm.86a.17118
DP  - 2019 Mar 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 179--186
VI  - 86
IP  - 3
4099  - http://www.ccjm.org/content/86/3/179.short
4100  - http://www.ccjm.org/content/86/3/179.full
SO  - Cleve Clin J Med2019 Mar 01; 86
AB  - Staging of liver fibrosis is increasingly done using noninvasive methods, in some cases obviating the need for liver biopsy. Scores based on laboratory values and demographic variables have been developed and validated for assessing fibrosis in patients with hepatitis C virus (HCV) infection and nonalcoholic fatty liver disease (NAFLD), as have several imaging methods that measure shear-wave velocity, a reflection of fibrosis severity.